Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): study protocol for an adaptive randomized controlled trial

Mostrar otras versiones (1)

BACKGROUND: Highly effective, short-course, bedaquiline-containing treatment regimens for multidrug-resistant tuberculosis (MDR-TB) and integrase strand transfer inhibitor (INSTI)-containing fixed dose combination antiretroviral therapy (ART) have radically transformed treatment for MDR-TB and HIV....

Descripción completa

Detalles Bibliográficos
Autores principales: Ross, Jesse, Perumal, Rubeshan, Wolf, Allison, Zulu, Mbali, Guzman, Kevin, Seepamore, Boitumelo, Reis, Karl, Nyilana, Hlengiwe, Hlathi, Senzo, Narasimmulu, Radhamoney, Cheung, Ying Kuen K., Amico, K. Rivet, Friedland, Gerald, Daftary, Amrita, Zelnick, Jennifer R., Naidoo, Kogieleum, O’Donnell, Max R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691086/
https://www.ncbi.nlm.nih.gov/pubmed/38037105
http://dx.doi.org/10.1186/s13063-023-07520-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691086/
https://www.ncbi.nlm.nih.gov/pubmed/38037105
http://dx.doi.org/10.1186/s13063-023-07520-9

Ejemplares similares